Aurobindo Pharma receives US regulatory nod for Acetaminophen injection
Aurobindo Pharma receives US regulatory nod for Acetaminophen injection

Aurobindo Pharma receives US regulatory nod for Acetaminophen injection

Anthony Fernandes Article rating: 5.0

On Thursday, Aurobindo Pharma informed that it has received final approval from US Food & Drug Administration (USFDA) to manufacture and market Acetaminophen injection, 1,000 mg/ 100 ml single-dose vial (SDV), which is a generic equivalent of Mallinckrodt’s Ofirmev injection.

Sensex, Nifty close in red; Tata Teleservices gains 9.57 per cent
Sensex, Nifty close in red; Tata Teleservices gains 9.57 per cent

Sensex, Nifty close in red; Tata Teleservices gains 9.57 per cent

Ganesh V Article rating: 3.7

On Thursday, the domestic benchmark indices closed in the red. The markets remained volatile during today’s trading session as Sensex closed down by 148.82 points or 0.37 per cent to settle at 40,558.49 levels while Nifty ended the session down by 41.20 points or 0.35 per cent to close at 11,896.45 levels.

New tax norms applicable to mutual funds
New tax norms applicable to mutual funds

New tax norms applicable to mutual funds

Henil Shah Article rating: 3.8

The new tax collected at source provision is applicable to mutual funds as well as alternative investment funds. Read on to find out more.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 4.0

The market opened in red October 22, 2020, overall volumes in futures & options currently stand at 4,55,61,450 contracts with a turnover of Rs. 33,02,118.97 crore.

RSS
First19521953195419551957195919601961Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR